sq-109

Also known as SQ 109, SQ109

SQ109 is a drug undergoing development for treatment of tuberculosis.

Chemical data

Formula: C22H38N2
Molecular weight: 330.5 g/mol
IUPAC name: N'-(2-adamantyl)-N-[(2E)-3,7-dimethylocta-2,6-dienyl]ethane-1,2-diamine
SMILES: CC(=CCC/C(=C/CNCCNC1C2CC3CC(C2)CC1C3)/C)C
InChIKey: JFIBVDBTCDTBRH-REZTVBANSA-N
XLogP: 5.1
Polar surface area: 24.1 Å²
H-bond donors: 2
H-bond acceptors: 2
Formal charge: 0

via PubChem

Drug data · ChEMBL

Max clinical phase: Phase 2
Molecule type: Small molecule
Indications: Helicobacter pylori infectious disease, tuberculosis

via ChEMBL · EBI

Wikidata facts

Mass: 330.303499

Show 3 more facts

chemical formula: C₂₂H₃₈N₂
isomeric SMILES: CC(=CCC/C(=C/CNCCNC1C2CC3CC(C2)CC1C3)/C)C
canonical SMILES: CC(=CCCC(=CCNCCNC1C2CC3CC(C2)CC1C3)C)C

Sources (2)

via Wikidata · CC0

~1 min read

Encyclopedic overview

3 sections

Contents

Background
See also
References

SQ109 is a drug undergoing development for treatment of tuberculosis.

==Background== On October 16, 2007, it was given the status of Orphan drug by the U.S. Food and Drug Administration (FDA) for use against drug-susceptible and drug-resistant TB bacteria.

Excerpted from Wikipedia’s “sq-109” article, available under the CC BY-SA 4.0 licence.

Available in 8 languages

via Wikidata sitelinks · CC0